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In these times of fiscal restraint, it is a pleasure to report on the success ofThe University of 
Tennessee College of Veterinary Medicine's Center of Excellence in Livestock Diseases. 
-
A quick perusal of this document will show that despite the shrinkage of funds from the USDA, 
.NIH, and other federal funding agencies, and the increased competition for these dollars, our
- researchers have been extraordinarily successful. The graph in Table I. indicates a thirteen 
percent decline in expenditures from grant funds for the last two years from a plateau in 1993 
through 1995. Although we would like to reverse this trend we understand the reasons behind it. 
- Basically, tightened funding and more competition has had a major effect; however, we have lost 
Dr. Ted McDonald from our research pool due to his retirement as well as another senior 
.. 	 researcher. Their contributions to this Center have been consistent over the years and we will 
have to rebuild this annual funding by starting at the bottom with young and promising 
researchers. We have already begun this process by recently hiring a young researcher with an 
excellent funding history who we anticipate will be successful in grant awards and by placing two 
-	 promising post-doctoral research students in the clinics on a half time basis. 
Despite a fall in grant funds our expenditures from current grants was over $2 million, which is a
- significant amount for this College. We have consistently managed, at the very least, to maintain 
this level since 1988. The expenditures reflected in the COE program are slightly over a 4: I 
return on state dollars invested in research. If one calculates this investment in relation to the 
-
- total amount ofgrants in this College from which these expenditures arise, a minimum of a 32: 1 
investment from state dollars will be shown. This certainly rivals, if not exceeds, the current surge 
in the stock market. 
At the same time, if one studies the benchmarks achieved this year, it will be seen that we have 
averaged over 7 articles in refereed journals per researcher. If this amount is added to book 
- chapters and proceedings there is a total of 249 publications, excluding abstracts, for the 
researchers in this Center during the year. In 1988 there were 23 scientists involved in the Center 
-
which resulted in 102 publications and in 1996/1997 there were 24 scientists resulting in 249 
publications. Those results prove a steady increase over the last nine years and a healthy return 
on the initial and subsequent award of funds . 
.. The reorganization we previously put into effect with respect to the committee responsible for 
evaluating and selecting scientists and proposals for funding, has been working extremely well. 
The investigators are fully informed of the scores given their proposals and if they are not funded 
.. 
-
they are provided the reasons and, perhaps, suggestions for improving proposals next time. The 
guidelines related to who should apply and what is required for successful funding are much 
clearer and easier to follow. 
-
.. 
-

-

-

Our mission has not changed in that we are still primarily motivated to: 
• help fund productive established researchers 
-
• fund promising new investigators 
• when necessary, help bridge funding gaps 
• fund students who are interested in a research career 
-
• continue to help with stipends for post-doctoral students 
We have also set aside small amounts to assist departments in providing maintenance contracts 
on equipment used by Center scientists. Another investment is a small amount of money to help 
- the Lab Animal Program better serve our scientists with respect to equipment and housing for 
research animals. 
- Dr. Leon Potgieter, the Assistant Director of the Center ofExcellence, has been a tremendous 
asset in organizing the Center and in managing the day to day functions. He is ably assisted by 
Ms. Diane Leslie who also helps coordinate the Graduate Program. This College is indebted to 
- these two for their hard work and expertise. It is not easy, nor does one make many friends, when 
unbiased rules are routinely applied to all researchers without favors. 
- This Center continues to produce significant research and resulting scholarly works at a very 
small cost to Tennessee taxpayers and provides a huge return on their investment. With the 
changing scene related to federal agencies and funding, we will continue to forge new 
- partnerships as opportunities arise. Obviously, the major changes at the Oak Ridge National 
. Laboratories will create new partnerships and we are already hard at work along these lines. 
- Sincerely, 
c::~~
- ~. -=~-
'~~~ 
-
Dean 
',jb 
-
-
-
-
-
-
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Center of Excellence 

Program Report (1996-97) 

Dr. Leon N D Potgieter, Assistant Director 
.. 
The Center of Excellence has been in existence for over twelve years. Although external 
.. funding levels have reached a plateau over the last five to six years (approximately $2.3 
million/year), the Center continues to grow in terms of its benchmarks. The Center of Excellence 
can be proud, in particular, of the number of peer-reviewed articles published by participants in 
-
1996-97 (total of 176 and a mean of 7.33 per member a record for the Center). A factor that 
has impacted the Center is the retirement of two very productive researchers and the resignation 
of a third over the past 18 months. Drs. Ted McDonald and Walter Farkas retired after many 
.. years of productive research at the University of Tennessee. Unfortunately, the uncertain budget 
projections for the State for the immediate future will allow us to fill only one of these positions. 
I am pleased to announce that we have been able to recruit Dr. Hwa-Chain Wang, an 
-
established and accomplished researcher in basic mechanisms of cancer therapy. He brings with 
.. 
him a well-funded research program. We have been fortunate also in recently recruiting Dr. Joe 
Bartjes, an eminent investigator in clinical nutrition. He has been well funded for research on 
nutrition in development of degenerative joint and other diseases. Both these investigators could 
have significant roles in the Center ofExcellence in the future. I may add that the existence of the
.. 
Center of Excellence was a major factor in the recruiting of researchers of this caliber. 
.. 
It is a tribute to our current COE participants that they have been able to maintain funding 
levels and increase productivity in spite of a very unfavorable funding climate and loss of research 
personnel. Drs. Barry Rouse, Hildegard Schuller and David Brian continue to be the main pillars 
.. 
of the Center's funding base. They are well supported by Drs. Erby Wilkinson, Terry Schultz, 
Linda Munson, Stephen Oliver, Sharon Patton, Charmi Mendis-Handagama, Alan Mathew, James 
.. 
Godkin, Darryl Millis and Melissa Kennedy. It is a pleasure to announce that Drs. Kevin Hahn 
and Jack Oliver also have received major awards. Dr. Hahn's award from Bayer amounts to 
approximately $450,000 for five years and involves use of an animal model (with naturally 
occurring tumors) for the treatment of certain cancers. Dr. Jack Oliver received nearly $200,000 
- from USDA for the study of mechanisms of fungus toxicity in cattle associated with tall fescue 
.. 

.. 

.. 
.. 
.. 
.. 
.. 
.. 
.. 
.. 
.. 
grass pastures. These awards clearly illustrate the national recognition for excellence of our 
investigators. The research potential of our recent recruits and the productivity of our current 
participants makes me optimistic for the future of the Center ofExcellence and that it will have a 
significant impact on the welfare of the people ofTennessee . 
III 
-
.. 
.. 
.. 
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 Major Research Activity in the Center of Excellence: 
-
Goal 1: To Improve the Quality of Human Life by Improving Animal Health 
-
-
Drs. Jack Oliver, Stephen Oliver, Philip Bochsler, David Brian, Alan Mathew,
- Donita Frazier and Sharon Patton made significant contribution to improving animal health 
over the past year. 
Mastitis in an inflammation of the mammary gland that affects almost 35% of dairy cows 
worldwide. Several different types of bacteria can invade the udder and cause inflammation
-
-
resulting in mastitis. The National Mastitis Council estimates that mastitis costs u.S. dairy 
producers in excess of $2 billion dollars annually. In Tennessee, costs associated with mastitis 
-
likely exceed $35 million dollars each year. Thus, mastitis continues to be one of, if not, the most 
significant limiting factor to profitable dairying in Tennessee, the U.S., and throughout the world. 
-
Dr. Stephen Oliver is charactetizing factors that affect resistance of the udder to mastitis 
and mechanisms that permit bacteria to invade the udder. His goal is to develop and evaluate 
-
procedures to enhance resistance of the udder. A major research focus has been on Streptococcus 
uberis, a frequent cause of mastitis. Strategies for controlling this pathogen are poorly defined 
and inadequate. During the last year, Dr. Oliver has identified some factors that allow 
Streptococcus uberis to invade the udder and cause mastitis. His laboratory is currently
-
characterizing and evaluating these factors. The long-term goal of this research is to develop a 
vaccine to control this important mastitis pathogen. 
-
Dr. Sharon Patton's laboratory is studying the risk factors involved in the transmission of 
Toxoplasma gondii in the U.S. It causes one of the most widespread protozoan diseases, 
-
infecting approximately ] 3% of the world population in both temperate and tropical countries. 
Congenital infection occurs when a woman is infected for the first time during pregnancy. It is
-
estimated that 4,100 of the 4. 1 million infants born annually in recent years in the US have the 
congenital infection. Toxoplasmic encephalitis is the second most common AIDS-related 
-
opportunistic infectious of the central nervous system. Estimated medical costs of congenital
-
.. 
3 
-

-

toxoplasmosis ranged from $368 million to $8.8 billion annually in the U.S., and in 1992 the cost 
for treating toxoplasmosis in AIDS patients was between $23 and $106 million dollars. 
- Humans are infected with postnatal Toxoplama gondii by eating tissue cysts in 
undercooked meat or food or by ingesting water contaminated with sporulated oocysts from cat 
.. 
- feces. Dr. Patton's laboratory has focused on the infection in swine. Toxoplasmosis has been 
identified as an emerging disease problem for the swine industry because of a perceived potential 
.. 
transmission from pork to humans. Consumer assurance of the safety of the pork they eat is vital 
to the swine industry. If perceived as an unclean product, the demand for pork and its image in 
the marketplace will deteriorate. This research will assist in providing answers on the 
pork/toxoplasmosis issue before it becomes a major industry problem that may impact Tennessee 
-
-
producers. 
Dr. Melissa Kennedy's work focused on the Coronaviridae. These viruses cause disease 
in many species of birds and mammals, including humans. They have been associated with 
diseases of the respiratory tract, nervous system, and reproductive system. She has characterized 
-
some of the molecular inter-relationships among several coronaviruses and has developed and 
.. evaluated molecular techniques to detect these viruses in affected and carrier animals . 
Dr. Donita Frazier has been working on the chemical modification of drugs by multiple 
enzyme systems since this is the most important factor in the body's regulation of drug
-
concentrations. It constitutes the major mechanism for altering the biological effects of a 
_ 	 compound and for its clearance from the body. The largest concentration of enzymes involved in 
these reactions (primarily cytochrome P450) is located in the liver, but significant concentrations 
also exist in the intestine. Although cytochrome P450 enzymes occur in all animal species, minor 
.:hanges in structure or tissue distribution, may allow great differences in the breakdown and 
.. elimination of specific drugs. A lack of consideration of the rates of inactivation and elimination 
of drugs in animals intended for food may result in drug residues in consumed meats. Also, 
ineffective concentrations of antibacterial drugs could occur, resulting in inadequate bacterial 
-
killing, leading to bacterial contamination of meats. Moreover, low antibiotic concentrations may 
favor development of resistant strains of bacteria. Dr. Frazier is determining the activities of 
-
specific cytochrome P450 enzymes in various tissues of swine and poultry and the role of these 
enzymes in the breakdown of quinolone antibiotics. 
-
-

-
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Goal 2: To Augment Livestock Disease Research Capabilities in the Institute of
- Agriculture 
-
Dn. Philip Bochsler, Melissa Kennedy, Stephen Oliver, Jack Oliver, David Brian, 
-
James Godkin, Linda Munson, and Joyce Merryman made significant contributions in 
livestock disease research by the Center this past year. 
Dr. Jack Oliver and co-workers have continued to research the mechanism(s) by which 
-
the fungal-produced toxins, prevalent in tall fescue grass, affect primarily herbivores. His 
laboratory seeks to find methods to significantly reduce losses that occur to the cattle industry, 
-
-
currently estimated at $10 million annually in Tennessee alone (see Goal 5). 
Respiratory diseases of cattle are a cause of significant economic loss for cattle and dairy 
operations in the state of Tennessee. White blood cells (leukocytes) are an important part of the
- immune system, contributing to a defense against infectious agents in the lungs of cattle as well as 
other animals. 
-
-
Dr. Philip Bochsler is investigating the mechanisms by which white blood cells provide 
protection against infectious agents that cause bovine pneumonia. This research is being done to 
understand the mechanism( s) by which organisms produce respiratory diseases in cattle. This 
research may eventually assist in formulating improved strategies for prevention and therapy of
-
these infectious diseases. He has determined that certain lung cells (alveolar macrophages) 
produce nitric oxide in response to certain organisms. Dr. Bochsler's research suggests that this 
-
sdbstance appears to have an important role in destroying infectious agents in the lung. He has 
evaluated factors that influence production and bacterial killing by this biological product. 
Coronaviruses cause some of the most costly respiratory and gastroenteric diseases in 
livestock and fowl. In recent years, new coronavirus pathotypes have emerged in the bovine and 
-
porcine species as a result of virus mutation. Coronaviruses also cause a variety of debilitating 
chronic disease in animals as a result of long-term persistent infection, a condition that is thought -
to contribute significantly to the emergence of new virus variants. Because of the special 
- challenges of inducing immunity at mucosal surfaces and because coronaviruses mutate rapidly, 
vaccines to control coronavirus often are not effective. Therapeutic measures to cure persistent 
-
5
-
.. 

-
 infections are not available because it is not known in detail how or where the chronic coronavirus 
infection is maintained . 
... 
Dr. David Brian's research has included coronaviruses that infect many species, including 
-
cattle. By studying the molecular biology of bovine coronavirus replication, he has identified 
potential sites in the viral genome for targeted antiviral therapy and uncovered two potential 
-
mechanisms of persistent infection. 
Dr. Alan Mathew recently determined, by biochemical analyses, that organisms 
-
associated with mastitis (milk fever) in swine herds are mostly of environmental origin and exist 
primarily in unsanitary areas. This is in contrast to animal pathogens commonly associated with 
... 
mastitis in dairy cows. Animal pathogen reservoirs are typically within the host animal. This 
finding should enable Dr. Mathew to develop therapeutic and/or management strategies for 
.. control of mastitis/milk fever in sows. He also has tested feed and water treatments to determine 
their effectiveness in preventing intestinal diseases that often occur following weaning in young 
... 
pigs. He specifically tested products naturally derived from the breakdown of carbohydrates in 
the intestine, known as volatile fatty acids. Natural concentrations of volatile fatty acids in the 
... gastrointestinal tract decrease rapidly following weaning and may be responsible for the reduced 
resistance to common intestinal infections such as E. coli. 
-
Vitamin A (retinol) is essential for reproductive processes. Severe retinol deficiency may 
inhibit reproductive cyclicity, ovarian development and ovulation. Moderate deficiency may result 
- in abortion, fetal resorption or congenital abnormalities. 
Dr. James Godkin studies the mechanisms by which vitamin A and derivatives regulate 
cell growth and development of reproductive tissues. He has discovered and characterized 
several proteins that specifically bind to these derivatives. Recent studies determined the role of 
- ovarian sex steroids and vitamin A derivatives in regulating production of these proteins in 
-
various tissues of the reproductive tract. An important discovery was that vitamin A treatment 
improved embryo quality in ewes. Research continues on developing treatments to manipUlate 
production of these critical proteins during ovulation and pregnancy, through optimizing 
-
reproductive efficiency. 
.. 
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Goal 3: To Identify and Characterize Laboratory and Animal Models of 

Important Human Diseases 

Dr. Eric Schultze has worked on the development of a mouse model for a certain type of 
anemia and iron storage disease of humans. His research focused on characterizing the results of 
genetic changes in a region called the fitness 1 locus in chromosome 7 of mice. Mice with 
mutations in the fitness 1 locus are stunted and develop growth abnormalities involving the spinal 
column (scoliosis). Fitness 1 mice also have a marked deficiency in the number of red blood cells 
(anemia) and evidence of liver dysfunction. He has evaluated the transportation of iron and 
copper and the concentrations of these metals in the tissues of the fitness 1 mice. Microscopic 
examination indicated that the bone marrow and spleen of these mice were abnormal. Red blood 
cell formation in the bone marrow was decreased, but was markedly increased in the spleen, 
probably due to the abnormal distribution of iron within the various organs. Analysis offitness 1 
mice organs for abnormalities in the concentrations of several other biologically important metals 
indicated that the problem is largely limited to iron and copper. Currently, the laboratory is 
examining the concentration of hemopexin and iron transport protein, found in the blood of 
people and mice, to determine if alterations in this protein might account for the abnormal iron 
metabolism in these mice. 
Drs. Dorcas Schaeffer and Erby Wilkinson continued to study the many abnormalities 
of the Tg737 mouse mutant. This mouse has major abnormalities in many organs including the 
kidney, liver and pancreas; these abnormalities resemble several genetic diseases of humans. They 
have further characterized the abnormal cells of the liver and determined that the main problem is 
the failure of the stem cells to differentiate into normal mature liver cells. These mutant cells also 
constitute a target cell for cancer formation. Studies of these mice indicated that the pancreas 
develops normally, but atrophies soon after birth. The animals lose weight and eventually die. 
The cause of the pancreas lesion is due to a failure of the duct stem cells to mature like the 
abnormal stem cells of the liver. 
Dr. Erby Wilkinson has studied two models of autoimmune disease of humans. One is 
the "scurfY mouse," and they have now determined that the disease is caused by the activation of 
- 7 
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-

-
a certain subset of immune cells (T lymphocytes). These T cells produce a number of cell 
products that activate other inflammatory cells and cause the wasting and inflammation that 
results in the death of the animals. His laboratory has generated considerable information on how 
these cells develop and become activated. They have also located the scurfy gene in a small 
- region of the X chromosome. This is a major breakthrough and ensures that the gene can be 
identified shortly. Dr. Wilkinson and his co-workers have screened over 100 lines of mice with 
- chromosomal abnormalities for immunological abnormalities. They have identified 10 lines of 
-
mice with genetically inherited mutations that cause different alterations of the immune system. 
Many of these mice lines could be useful animal models of human disease. 
Dr. Linda Munson has established a promising mouse model for human endometriosis, 
-
an important reproductive disease in women involving the uterus. She has established that 
immuno-deficient (SCID) mice which have had human endometrial epithelial cells on a matrix 
- implanted into the abdomen survive at least six weeks and even form rudimentary glandular 
sctructures.
-
Dr. Diane Hendrix has established a laboratory model for studying the healing 
_ characteristics of the injured cornea under various conditions (such as exposure to various 
treatments). The model involves the harvesting and growth of corneal epithelial cells (the 
_ outermost layer of the cornea). 
Dr. Melissa Kennedy has identified a coronavlrus in a colony of howler monkeys 
experiencing gastroenteritis, and in one case, weight loss and death. Because coronaviruses cause 
-
a variety of diseases in humans, this virus in primates may serve as a model for human disease. 
Characterization of the virus at the genetic level is ongoing, but it appears to contain some genetic 
-
material similar to a bovine coronavirus and to a feline coronavirus. This ana1ysis will be 
extended to other regions of the viral genetic material. If these results prove consistent, it would 
-
be the first time that coronavirus genetic material with characteristics of two very different 
coronaviruses has been identified. These findings may impact significantly our understanding of 
-
coronaviruses and their pathogenesis in its host. 
-
-
- 8 
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 Goal 4: To Study AnimallLaboratory Models for Better Understanding 
-
of Human Disease 
-
Several COE researchers utilized animal models in their studies over the past year of 
-
disease processes in humans. They included Drs. Hildegard Schuller, Erby Wilkinson, Kevin 
Hahn, Barry Rouse, Eric Schultze, Terry Schultz, Joyce Merryman and Darryl Millis. 
-
Dr. Charmi Mendis-Handagama's research focuses on implications concerning the 
mechanisms of fertility in animals and humans. She is studying the process of Leydig cell 
-
formation in the developing mammalian testis using the rat model. Her research has revealed that 
thyroid hormones has this crucial role in the developing mammalian testis to establish the adult 
-
Leydig cell population. This important disclosure is a breakthrough in the field of pediatric 
endocrinology . 
-
Dr. Hildegard Schuller continues to study the role of the autonomic nervous system in 
the induction and progression of different types of lung cancer. Dr. Schuller's research has 
-
previously shown that nicotine can cause lung cancer in individuals with chronic lung disease by 
binding to certain (cholinergic) receptors expressed in certain ( neuroendocrine) lung cells. This 
-
initiates a cascade of intracellular chemical reactions that stimulate abnormal cell proliferation and 
tumor formation. This is a very important finding because it now allows for the development of 
.. 
cancer therapeutics that selectively block the growth of neuroendocrine lung cancer without 
affecting other lung cell types. Dr. Schuller determined that theophylline selectively blocks one 
-
step of these intracellular reactions. Theophylline is the active ingredient of drugs that dilate the 
bronchi, and which are widely used for the treatment of bronchitis and asthma. Accordingly, 
-
these drugs are already approved for the safe use in human patients and can be immediately tested 
as therapeutics for small cell lung cancer. Theophylline is also contained at a high concentration 
-
in green and black tea, and an experiment in hamsters is currently underway to test the potential 
chemopreventive effect of green tea on neuroendocrine lung cancer. 
-
In a series of experiments in collaboration with Dr. Merryman, Dr. Schuller has 
addressed the question in the laboratory of why chronic lung disease is a risk factor lung cancer 
-
and promotes the development of lung cancer caused by nicotine. This research has identified 
carbon dioxide as an important messenger molecule for small cell lung cancer. 
- 9 
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Dn. Dorcas Schaeffer and Erby Wilkinson reported on the Tg737 mouse that has 
major abnormalities in many organs such as the kidney, liver and pancreas resembling certain 
human diseases. They showed that the disease is influenced by a misplacement of a growth factor -
receptor on the wrong side of the cells that line the kidney tubules. This implies that inhibitors of
- this receptor, currently being developed by pharmaceutical companies, potentially could be used 
as a treatment for the disease. They demonstrated that partial replacement of the abnormal gene 
- in this mouse dramatically retards progression of the disease. Gene therapy therefore should be a 
useful treatment for this common and deadly disease. 
- Dr. Erby Wilkinson's work targets animal models of immunological diseases in humans. 
He has completed analyses of transgenic mice with certain immune cells (T cells) that over­
-
-
produce certain proteins. One of these proteins has the capability of activating replication of 
human immunodeficiency virus. With their enhanced immune responses these animals will be 
useful in identifying the factors involved in several important diseases with abnormal immune 
-
functions. Another mouse model studied in Dr. Wilkinson's laboratory is the Wiskott-Aldrich 
-
disease, a fatal disease of males characterized by immune deficiencies, bleeding and eczema. 
These animals also have markedly enhanced immune responses. The researchers have determined 
-
that T cells markedly stimulate the antibody-producing immune (B) cells in the animals. The latter 
discovery could lead to important advances to increase the immune response to harmful agents. 
Mechanisms to dissect the Wiskott-Aldrich gene, have been developed, a first step in producing 
potential treatments and cure. 
-
Lymphoma is a common and fatal cancer in people, dogs and other animals. While there 
is no known cure, the progression of the disease can be slowed by administering anti-cancer drug 
-
therapy. Though these drugs are successful and many patients may enjoy an extended life span, 
relapses are common resulting from resistance of the cancer cells to the drugs that are used. 
-
Doxorubicin is an anti-cancer drug commonly used to control lymphoma. 
-
Dr. Kevin Hahn and co-workers have conducted a one-year pilot study in the dog model 
addressing how lymphoma cancer cells become resistant to the anti-cancer effects of doxorubicin. 
He measured the amount of a specific protein in the blood that may appear when the cancer cells 
-
begin to develop drug resistance. He evaluated whether the presence of this protein could indicate 
- lymphoma cells in a patient had become resistant to doxorubicin prior to and/or dUling 
- 10 
-

.. 

.. 

doxorubicin treatment Preliminary results in the laboratory suggested that changing levels of this 
protein do reflect an increased resistance of the cells to doxorubicin exposure. The benefit of this
.. 
study is the potential use of a simple blood test to determine whether a patient's cancer cells have 
already developed resistance to a particular anti-cancer drug prior to treatment. An elevated
.. 
protein level would suggest using alternative anti-cancer drugs, thus providing better care for the 
tumor-bearing patient and avoiding the use ofcostly and unnecessarily toxic drugs. 
- Tennessee is one of the top five air polluting states in the nation. Methods predicting 
toxicity of chemicals could aid industry and state and local governments in making accurate 
judgments regarding chemical toxicity. 
Over the past year, Dr. Terry Schultz's laboratory has focused on predicting the toxicity 
-
-
of highly reactive industrial materials using biological activity testing and mathematical modeling 
procedures. This past year efforts centered on quinones, an environmentally important class of 
aromatic compounds. Researchers established the exact chemical reactivity mechanisms of these 
.. compounds that relate to their toxicity. They identified also the nature of the chemical 
substructures related to toxicity. This information allows them to predict the toxicity of new 
compounds of this class. 
Dr. Linda Munson has worked on human endometriosis and endometrial cancer using 
laboratory and animal models. These diseases are common reproductive diseases in women but 
- little is known about the specific factors that influence their development. A signaling chemical, 
.. platelet derived growth factor, appears to influence the normal cyclical growth ofuterine epithelial 
cells. Studies in Dr. Munson's laboratory have determined that various uterine epithelial cells 
.. express different levels of the growth factor receptor. Preliminary evidence indicated that uterine 
carcinoma cells all express the growth factor receptor. The laboratory studies indicate that 
.. estrogens may markedly enhance the expression of these growth factors on uterine epithelial cells 
and thereby promote their proliferation. These findings may impact current concepts of hormone 
.. replacement therapy in women . 

Dr. Joyce Merryman's research has focused on the effect of environmental hazards on 

.. cells, especially ultraviolet radiation present in sunlight. Skin cancer is the most common type of 
cancer in Caucasians, with a lifetime risk greater than the risk for all other cancers combined. 
Ultraviolet radiation causes damage to the cellular DNA that ultimately may result in skin cancer. 
11 
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-

Consequently, she has been investigating the role of tumor suppressor genes, growth-regulatory 
-
factors and intracellular communication pathways involved in the development of skin cancer. 
The development of an in vitro reconstituted skin model, a system whereby cells isolated from 
-
nonnal skin are grown in the laboratory in such a fashion that they resemble nonnal skin, is critical 
to these investigations. She now has perfected this technique so that ultraviolet radiation-induced 
-
damage to skin can be studied under tightly controlled conditions. With this model system, Dr. 
Merryman has been able to demonstrate the importance of a tumor suppressor gene in the 
-
development of skin cancer. 
Dr. Darryl Millis' research involved the use of bone growth factor to enhance bone 
-
fracture healing. Delayed healing of fractures is relatively common in people and costs millions of 
dollars in additional treatment costs and lost productivity. Dogs also have delayed healing of 
-
fractures and it is through the use of a canine model of bone healing Dr. Millis has determined 
that growth hormone and insulin-like growth factor to be effective in promoting healing of 
-
fractures. 
-
Goal 5: To Understand the Pathogenesis and Characterize the Causative 
-
Agents of Common Diseases Important to the State of Tennessee 
-
The research focus of many COE investigators is to dissect mechanisms and causes of 
disease production in animals and humans. Researchers who contributed significantly to this field 
-
over the past year included: Drs. Barry Rouse, Philip Bochsler, Jack Oliver, Thomas 
Doherty, Erby Wilkinson, Dave Brian, Hildegard Schuller, Joyce Merryman, Alan 
-
Mathew, Steve Oliver, Melissa Kennedy and Eric Schultze. 
Dr. Barry Rouse's laboratory has investigated the development of disease caused by 
-
herpesviruses and their prevention and treatment. Researchers have established that lesions of 
herpes keratitis are caused by the body's response to viral infection and become progressive with 
-
recrudescence. Their work established that anti herpes simplex certain immune cells (CD4+ THl) 
orchestrate virus inflammatory responses. Functions mediated or dependent on such cells may 
-
provide logical targets to minimize the impact of inflammatory responses. Their data established 
- 12 

-

-
 that one product of these cells, IL-I0, modulates the degree of the inflammatory response, and 
that several other cell products given prophylactically could alter development of the viral 
- immuno-inflammatory disease. 
Dr. Jack Oliver and co-workers have recognized and documented that toxins produced 
- by the fungus in tall fescue (and other grass/weed species) first cause changes in the blood vessels 
-
of animals, and are followed by generalized tissue/organ inflammation. In response to the toxins, 
the lining cells of blood vessels produced chemical substances that cause vessels to contract and 
.. 
the walls of the vessels to become thickened, changing blood flow to tissues and organs. Other 
chemicals were released that promoted blood clotting, likely interfering with air exchange in the 
.. 
lungs, and contributing to the well-known heat stress experienced by affected animals. In severe 
toxic cases, these same chemicals would prevent blood flow to peripheral areas (feet, tips of ears, 
and tail) resulting in death and loss of the tissues. Changes in normal blood components in 
-
response to toxin presence were documented, and changes indicated impaired functioning of the 
.. liver and blood-forming organs. These changes could slow the growth of animals and be 
responsible for the major economic problem associated with the disease. The finding of the 
.. irritative and destructive nature of the toxins on blood vessels will allow Dr. Oliver to focus 
attention on this primary lesion and to test the effectiveness of anti-inflammatory drugs for its 
.. prevention . 
Dr. Thomas Doherty has studied the effect of endotoxin (part of a cell wall of certain 
.. bacteria) on the bowel function in animals. Endotoxin, even at a low dose, causes bowel motility 
to cease and results in a serious medical condition. Lidocaine, a local anesthetic, effectively 
.. blocks the effects of endotoxin in a laboratory model (rabbit). However, horses do not benefit in 
the same way from lidocaine indicating species differences exist in the ability of lidocaine to block 
the endotoxin effect. 
-
.. 

.. 

-

.. 
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 Goal 6: To Improve the Capabilities of the College of Veterinary Medicine, the 
-
College of Agricultural Sciences and Natural Resources, and the Agricultural 
Experiment Station to Deal with these Diseases 
-
Dn. Barry Rouse, David Brian, Jack Oliver, Steve Oliver, Hildegard Schuller, Erby 
- Wilkinson, David Bemis, Kevin Hahn, Alan Mathew and James Godkin have done research 
resulting in exciting discoveries regarding treatments and prophylaxis of various infectious and 
- genetic diseases and cancer. These discoveries are discussed in some detail under Goals 1,2,4,9 
and 11.
-
Goal 7: To Improve Facilities to Enable the College of Veterinary Medicine to 
- Study More Effectively Infectious and Toxic Diseases of Animals 
-
After several years of anticipation, the Biotechnology Animal Science Facility is nearing 
- completion. This facility includes two large laboratory animal rooms and a student teaching area. 
I anticipate that over 2000 fe will become available in the College of Veterinary Medicine 
- Teaching Hospital on the second floor as the result of moving some aspects of the teaching 
program and laboratory animal housing to the new facility. Our strategic plan calls for converting 
- at least some of the space for research activities. 
An addition to the College ofVeterinary Medicine was completed during the past year. It 
includes an office complex for the Office for Laboratory Animal Care, offices for the 
-
laboratory animal veterinarians, and space for the computer support staff. These programs 
impact the research program and their relocation has given some relief for housing graduate 
-
-
students and post-doctoral fellows. 
The building addition also allowed the college to construct a cobalt radiation unit, with 
both clinical and research applications. 
-
-
- 14 
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Goal 8: To Disseminate Through the Extension Service Practical Information 
Required to Reduce the Incidence of Livestock Diseases 
.. 
.. 
The efforts of Dr. Nancy Howell, (public information coordinator), the veterinary 
extension personnel and researchers continue to ensure that the College of Veterinary Medicine is 
featured in many national, regional and statewide publications. Research projects and data 
.. pertinent to Tennessee interests constitute a significant proportion of the media releases and 
informational displays. Many of the research articles featured were written by COE personnel, 
.. 
who have also taken advantage of invitations to speak to commodity groups at Tennessee 
Agricultural Experiment Station field days and at formal extension service programs. Publications 
have appeared in UT Agriculture (published for a statewide readership by the Institute of -
Agriculture), Veterinary News (for practitioners), Veterinary Medical Topics (published twice 
.. yearly by the extension service), two alumni publications (UT Alumnus and Torchbearer) and in 
Context (UT faculty/staff newsletter). Research being conducted by the Center is disseminated
.. 
also via the World-Wide Web. The University of Tennessee College of Veterinary Medicine has a 
home-page (http://www.vet.utk.edu/vetl) . 
.. 
Goal 9: To Develop New Strategies for the Prevention of Disease 
.. Drs. David Bemis and Stephen Kania have been studying, at the molecular level, the 
bacterium Bordetella bronchiseptica, an important cause of respiratory tract disease in swine, 
.. horses, certain laboratory animals and certain companion animals. They identified a unique gene 
that encodes a major surface protein present only in virulent strains of the bacterium. It is a 
.. variant fimbrial protein that enhances the organism's capacity to attach to cells and thereby initiate 
infections. Because this new fimbrial protein is one of the major antigens recognized by the body 
.. during infections, it is a good candidate for use as a vaccine. Consequently, the gene has been 
cloned and sub-cloned. The fascinating potential of this study is that the gene appears to be
-
.. 
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-
 amenable to insertion of carrier immunizing molecules and therefore could serve as a carrier for 
-
multiple vaccines to protect the respiratory tract. 
Dr. Barry Rouse has pioneered the technology of naked DNA vaccines that has become 
-
the new paradigm for the science of vaccinology. Infection of neonates with herpes and other 
viruses may occur at birth as a consequence of vaginal delivery to infected mothers. Dr. Rouse 
-
used a mouse model to investigate whether DNA vaccines could protect neonates from herpes 
simplex virus infections. Researchers demonstrated the efficacy of DNA vaccination in neonates 
-
both in the induction of specific antibody and cell-mediated immune responses and, more 
importantly, against challenge inoculation with the virus. Moreover, passive immunity did not 
-
interfere with the responses to DNA vaccination but did prevent immune responses to 
conventional vaccines. The use of small pieces of DNA encoding immunizing components of an 
-
organism could enormously improve the efficiency of vaccines used in human and veterinary 
medicine. It has been a particularly difficult to immunize young animals with passive antibodies. 
-
Dr. Dave Brian has discovered, through recombinant technology, innovative mechanisms 
to deliver immunizing materials to an animal (see Goal 11). 
-
Goal 10: To Improve Facilities and Expertise in Order to Provide Improved 
- Research Training 
- Equipment 
-
As in prevIous years, several multi-user pieces of equipment were bought for COE 
researchers over the past year. Strategic equipment purchases last year include: robotic liquid 
-
handling system, microplate scintillation and luminescence counter, air thermo-cycler, 
ELISA plate reader, automated histochemistry unit, preparative protein purification 
-
system, automated burette titrator and several powerful laboratory computers. 
.. Graduate Students and Postdoctoral Researchers 
In the past, the training component of the Center of Excellence has been small, but one of 
-
high quality. This past year, funds were used to support stipends for graduate students or 
- 16 
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-
 postdoctoral researchers for Drs. Brian, Munson, S. Oliver, Rouse, Schuller, Schultz, and 
-
Wilkinson. 
A major achievement by the Center of Excellence has been the funding by the National 
-
Institutes of Health of a large institutional training grant. The success of this grant application 
was largely due to the efforts of Dr. David Slauson, the primary author of the proposaL The 
-
grant will support five selected graduate students/residents in the Comparative and Experimental 
Medicine Graduate Program. The training program will be a collaborative effort of the 
.. 
Department ofPathology and the biology division of the Oak Ridge National Laboratory, and will 
emphasize "cellular pathobiology of environmental disease." The central goal of this training 
.. 
effort is to provide outstanding research opportunities for young pathologists in highly focused 
quality research laboratories with excellent quality control. Dr. Sharon Witonsky is completing 
.. 
her Ph.D. in this program; her work has involved characterization of immune mediated diseases of 
certain lines of mice. Dr. Barbara Sheppard was appointed July 1, 1996. Dr. Sheppard has 
.. special interests in diseases ofthe nervous and immune systems . 
Twelve veterinary students received modest COE summer stipends to allow them to 
-
participate in research in laboratories directed by COE faculty. Funds were allocated on a 
competitive basis. 
-
Four faculty also received modest funding for "venture" grants. The criteria for allocating 
the latter included scientific merit and potential of the work to lead to future funding . 
.. 
-
Goal 11: To Develop Innovative Approaches to the Treatment of Human 
Disease 
- Drs. Dorcas Schaeffer and Erby Wilkinson have treated a genetic disease in an animal 
-
model by partial replacement of an abnormal gene (see Goal 4). Their study of abnormal stem 
cells of the pancreas may lead to identification of factors that can promote regeneration of the 
-
pancreas following injury. 
Dr. David Brian, studying the molecular biology of coronaviruses, discovered a particle 
(subviral replicon) representing only a portion of the virus, but still capable of multiplication in 
.. 
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-
 cells. He has exploited the discovery by creating a molecular "Trojan Horse" to destroy certain 
-
viruses. The particle has been cloned and engineered to carry into infected cells a ribozyme-a 
potent specific antiviral molecule that cleaves a vulnerable site within an essential viral gene 
-
(RNA polymerase gene) and blocks virus replication. The subviral replicon also has been 
engineered to carry immunogens ofother viruses making it a new vaccine vector. 
-
Dr. Barry Rouse has developed methods of preventing and treating herpesvirus-induced, 
immuno-inflammatory disease by administering small pieces ofDNA encoding products produced 
-
by certain cells involved in the immune response. This pioneering work promises to provide 
practical methods for dealing with immune-mediated disease that has frustrated the medical 
.. 
profession for a long time (see Goal 5) . 
Dr. Hildegard Schuller is evaluating the use of theophylline to specifically inhibit the 
-
growth of neuroendocrine lung cancers because of a discovery that it may interfere with a 
chemical chain reaction involved in these cancers (see Goal 4). 
-
.. 
-
.. 
-
-
.. 
-
-
.. 
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Benchmarks 

Table 1. 

Center of Excellence for Livestock Diseases and 

Human Health 

External Funding Expenditure Levels Since 

Establishment 

$3,000,000 
$2,000,000 
$1,000,000 
84-85 85-86 86-87 87-88 88-89 89-90 90-91 91-92 92-93 93-94 94-95 95-96 96-97 

Years 
I I I I I I I I I I I I I I I I I I I 
TABLE 2 
CENTER OF EXCELLENCE IN LIVESTOCK DISEASES AND HUMAN HEALTH BENCHMARKS OF FACULTY ACCOMPLISHMENTS 
FACULTY MEMBERS ASSOCIATED WITH mE CENTER OF EXCELLENCE 
Year 5 
(Final Year of Initial 
Commitment Center) 
1988-1989 
Year 6 
(Year 01 as 
Accomplished Center) 
1989-1990 
Year 7 
(Year 02 as 
Accomplished Center) 
1990-1991 
Year 8 
(year 03 as 
Accomplished Center) 
1991-1992 
Target Actual Avg Actual Avg Actual Avg Actual Avg 
Number of: 
Articles 74 (3.22) 68 (2.62) 97 (3.73) 83 (4.37) 
Books or Book Chapters 7 (0.30) 17 (0.65) 14 (0.54) 6 (0.32) 
Published Proceedi~s 21 (0.91) 37 (1.42) 42 (1.62) 24 (1.26) 
Total Publications 2.82 102 (4.43) 122 (4.69) 153 (5.89) 113 (5.95) 
Abstracts 0.30 33 (1.43) 66 (2.54) 48 (1.85) 47 (2.47) 
Invited Participation at: 
Regional Meetin2s 0.50 36 (1.56) 19 (0.73) 28 (1.08) 13 (0.68) 
National Meetinp 1.25 55 (239) 28 (1.08) 44 (1.69) J6 (1.89) 
Faculty in Center 13 26 26 19 
Number of Visitors 10 17 17 12 
Year 9 
(Year 04 as 
Accomplished Center) 
1992-1993 
Year 10 
(Year 05 as 
Accomplished Center) 
1993-1994 
Year 11 
(Year 06 as 
Accomplished Center) 
1994-1995 
Year 12 
(year 07 as 
Accomplished Center) 
1995-1996 
Year 13 
(year 07 as 
Accomplished Center) 
1996-1997 
Actual Avg Actual Avg Actual Avg Actual Avg Actual Avg 
Number of: 
Articles 78 (3.90) 95 (5.00) 132 (6.29) 153 (7.29) 176 (7.33) 
Books or Book Chapters 7 (0.35) 9 (0.47) 5 (0.24) 5 (0.27) 5 (0.21) 
Published Proceedings 17 (0.85) 11 (0.58) 37 (t.76) 65 (2.95) 71 (2.96) 
Total Publications 102 (5.10) 104 (5.47) 174 (8.29) 223 (10.62) 249 (10.38) I 
Abstracts 53 (2.65) 55 (2.89) 42 (2.00) 64 (3.05) 71 (3.01) 
Invited Participation at: 
Regional Meetings 15 (0.75) 18 (0.95) 41 (t.95) 55 (2.62) 68 (2.83) 
National Meetings 47 (2.35) 47 (2.47) 65 (3.10) 70 (3.18) 76 (2.92) 
Faculty in Center 20 19 21 22 24 
Number ofVisitors 12 13 15 18 18 
I I I I I I I I I I I I I I I I I I I 

TABLE 3 

RESEARCH PROJECTS FUNDED EXTERNALLY 

REPORT PERIOD 1996-97 

PROJECT DIRECTOR TITLE OF GRANT FUNDING AGENCY TOTAL AWARDED ESTIMATED 
EXPENDITURES 
David Bemis Bordetella bronchiseptica adhesion molecules as USDA 1433 Funds S 9,000.00 S 5,444.07 
protective immogens and markers of host 10/01/96-9/30/97 
specificity 
Philip Bochsler Purification and characterization of bovine USDA SI84,000.00 S 78,651.80 
lipopolysaccharide-binding protein (renewal) 8/31197 
The role ofnitric oxide as a mediator of host USDA 1433 Funds S 6,852.00 $ 6,852.00 
defense in cattle 10/01/95-9/30/96 
Mechanisms of innate resistance to enteric USDA 1433 Funds S 8,322.00 $ 3,548.50 
pathogens of bovine calves 10/01/96-9301197 
David Brian Bovine corona virus vector for mucosal immunity to USDA SI40,000.00 S 10,854.64 
phaemolytica leukotoxin 9115195-9/30/98 
Mechanism(s) of coronavirus RNA replication and National Institute of Allergies and S228,871.00 $ 99,994.65 
packaging Infectious Diseases 7/01/96-6130/01 
Thomas Doherty Evaluation of gastric emptying in an endotoxin­ USDA 1433 Funds S 5,000.00 $ 1,195.00 
induced ileus model in the horse 10/01/96-9/30197 
Donita Frazier Comparative cytochrome P450 drug metabolism USDA 1433 Funds $ 4,000.00 $ 101.00 
pathways of fish, poultry, and swine 10/01196-9130197 
James Godkin Retinoids in bovine follicular and oocyte USDA Formula Funds S 5,000.00 $ 5,000.00 
development 10/01195-9/30/96 
Retinoid-binding protein and receptors in bovine USDANRI $212,000.00 S 34,913.34 
placental development 9/01/93-8131197 
Maintenance of pregnancy in cattle and sheep. AESHatch S 15,000.00 S 3,748.37 
7/01/96-6130197 
Kevin Hahn Serodiagnosis of Doxorubicin resistance in dogs Morris Animal Foundation S 3,000.00 S 2,003.77 
9/01196-11130/97 
Melissa Kennedy Detection f feline infectious peritonitis virus and Morris Animal Foundation S 19,000.00 S 12,623.03 
differentiation from feline enteric coronavirus 9/01/94-8131/96 
Characterization of7A and 7B open reading frames Pfizer Company $ 8,750.00 $ 8,699.75 
of feline coronaviruses 7/01196-7/31/97 
I I I I I I f I I I I I I I I I I I I 
Kennedy - Continued Identification and expression of FIPV-specific 
peptides and their use in FIPV-specific ELISA 
Morris Animal Foundation $ 23,725.00 
10/01/96-10/31/98 
$ 2,666.56 
Alan Mathew Evaluation of fiber blends, enteric micro flora, and 
diet digestibility in cats with ileal cannulas 
lams Company $113,054.00 
2101/96-12131/97 
$ 50,298.01 
Effect of volatile fatty acids on postweaning 
colonization ofEscherichia coli and Salmonella 
choleraesuis in pigs 
USDA 1433 Funds $ 4,000.00 
10/01/95-9/30/96 
$ 4,000.00 
Weaning and colonization of E. coli in the intestine 
of young pigs 
AESHATCH $ 52,000.00 
10/011193-9/30/97 
$ 10,931.43 
Characterization of mastitis causing agents in swine AESHATCH $ 11,666.00 
10/01/96-9/30/97 
$ 11,666.00 
Charmi Mendis-
Handagama 
Effect of galactosyllactose on calf starter diets 
(Co-PI) 
Regulation of testosterone production in adult rat 
testis 
Snow Brand Milk Products Co. 
National Science Foundation 
$ 30,000.00 
$ 18,000.00 
8115/94-1131197 
--------­
$ 12,911.72 
Increasing the spenn counts in testes of bulls using 
the transient hypothyroid treatment 
URCEO, France $ 24,000.00 
1/97-1/99 
--------­
Darryl MiDis The use of canine recombinant somatotropin to 
enhance fracture healing in dogs 
Monsanto Company $ 47,320.00 
5/01/96-7/01/97 
$ 39,320.22 
Pilot study of a new anti-inflammatory drug for 
synovitis 
G.D. Searle and Company $ 50,749.00 
9119/96-6/30/97 
$ 39,652.84 
Length of treatment time with canine recombinant 
somatotropin for ostectomy healing in an tmstable 
gap fracture healing model 
Protiva Company $ 65,342.00 
01101197-12/31101 
$ 30,519.79 
Initial dose determination of a new 
cylcoaxygenase-2 inhibitor for the prevention of 
lameness induced by chemical synovitis in dogs 
Protiva Company $ 83,215.00 
06/01/97-5/31/98 
$ 11,359.47 
Modulation of osteoarthritis with somatotropin and 
polysulfated glycosaminoglycans in dogs using the 
pond-nuki model 
Protiva Company $ 77,413.00 
06/01/97-5/31/99 
$ 4,202.03 
Linda MUDson Contraceptive health smveillance center for zoo 
and wildlife species. 
Geraldine R. Dodge Foundation $ 30,000.00 
10/01/95-1/31/97 
$ 17,713.89 
Continuing safety assessments of contraceptives for 
non-domestic felids 
American Association of Zoo Parks and 
Aquarium 
$128,414.00 
10/01/93-8/31/97 
$ 50,829.84 
Contraceptive health smveillance center for zoo, Geraldine R. Dodge Foundation $ 25.000.00 
--------­
wildlife, and companion animals 01101197-12131197 
--------
--------
--------
---------
---------
---------
-------
---------
I I I I I I I I I I I I I I I I I I• 

Jack Oliver 
Stephen Oliver 
Sharon Patton 
Characterization ofserum clinical chemistry 
analyte profiles of cattle grazing endophyte-free 
and endophyte-infected tall fescue grass 
Anti-fescue toxicosis vaccine development 
Anti-fescue toxicosis vaccine study (Co-PI) 
Endothelin response to tall fescue stimulus of 
bovine endothelial cells (Co-PI) 
Comparison ofplasma cortisol concentrations after 
stimulation with freshly reconstituted and 
previously frozen and stored cosyntropin clinically 
normal dogs (Co-PI) 
The effect of exogenous oral melatonin 
administration on sex hormone prolactin and 
thyroid concentrations in healthy sexually intact 
adult dogs (Co-PI) 
Identification, characterization, and evaluation of 
Streptococcus uberis virulence factors 
Efficacy of two novel experimental postrnilking 
teat disinfectants for the prevention of mastitis in 
dairy cows ooder natural exposure conditions 
Influence of clinical and subclinical mastitis during 
early lactation on reproductive perfonnance of 
Jersey cows 
Influence of intramammary antibiotic therapy at 
calving on mastitis and lactational perfonnance of 
heifers during early lactation 
Evaluation of specific immooe responses and 
protection by novel streptococcal antigens 
Lactation/mastitis research 
Hormonal changes associated with clinical mastitis 
during early lactation in Jersey cows (Co-PI) 
Toxoplasma goodii in swine populations: A 
comparison of the percentage of sows and market-
weight pigs infected from the NAHMS, farm 
management practice relationships, and economic 
costs 
USDA 1433 Foods 
USDA 1433 Foods 
Merck and Company 
USDA 
American College of Veterinary 
Dermatology 
American College of Veterinary 
Dermatology 
USDA Formula Foods 
Farnam Companies, Inc. 
American Jersey Cattle Association 
Research F ooodation 
The Upjohn Company 
PfIZer Company 
Robert L. Schattner F oWldation 
American Jersey Cattle Association 
Research FOWldation 
National Pork Producers 
$ 10,000.00 
10/01/95-9/30/96 
$ 11,000.00 
10/01/96-9/30/97 
$ 60,000.00 
1/01/95-12131/96 
$ 60,002.00 
3/01195-8131196 
$ 2,250.00 
7/01196-6130/97 
$ 3,000.00 
4/01197-3131198 
$ 7,000.00 
10/01/95-9/30/96 
$ 69,600.00 
1995-96 
$ 6,000.00 
1996 
$ 38,250.00 
1995-97 
$108,848.00 
4/97-12198 
$ 65,000.00 
6/97 
$ 6,000.00 
1996 
$ 24,500.00 
9/01196-8131197 
$ 10,000.00 
$ 11,000.00 
$ 7,000.00 
$ 3,395.19 
$ 20,534.00 
$ 10,454.21 
I I I I r I r I 	 I I I I I I I I I I• 
Patton - Continued 	 Epidemiology of Toxoplasma goodii in swine USDA 1433 Funds $ 11,000.00 
populations: A comparison of the seroprevalence 10/1195-9/30196 $ 11,000.00 
of Toxoplasma gondii in hogs and market weight 
pigs in the NAHMS, tinm management practice 
relationships, and economic costs 
Bart Rohrbach 	 Randomized clinical trial to evaluate the effect of Fort Dodge $ 27,845.00 
vaccination against Leptospim spp to prevent ERU 5115197-81151-98 
in horses. 
Barry Rouse 	 Herpes zosterftlization Smith-Kline Biological $124,746.00 --------­
7/1190-12131104 
Mucosal inununity in control of herpetic infection 	 National Institute ofAllergy and $728,711.00 $ 209,616.29 
Infectious Diseases - Nlli 1993-97 
Inununity mechanisms in herpesvirus infections 	 National Institute ofAllergy and $783,510.00 $ 254,241.53 
Infectious Diseases - Nlli 1995-00 
Mechanisms ofherpetic stromal keratitis National Eye Institute - Nlli 	 $1.047,093.00 $ 221,919.82 
1992-97 
Hildegard Schuller 	 Anticarcinogenic effects of Dexniguldipine-HcL in BYKGuiden $379,283.00 $ 20,442.60 
hamster 1993-97 
NNK effects on receptor pathways National Institute ofHealth 	 $599,126.00 $ 134,065.81 
1994-97 
Regulation of the proliferative response of Verum Foundation for Behavior and $128,484.00 $ 42,533.82 
pulmonary neuroendocrine cells to nicotinic Environment 1/96-12197 
agonists 
Transplacental pancreatic carcinogenesis by NN1 	 National Institute of Health $506,499.00 $ 184,945.48 
7/31197 
Terry Schultz 	 Development ofa bioremediation risk assessment US Environmental Protection Agency $ 54,749.00 $ 5,443.27 
scheme 9/94-9/97 
Structure-biodegradability/toxicity relationships of Dupont Corporation $ 40,000.00 $ 40,000.00 
substituted naphthalenes 6/95-6197 
The role of bioavailability in determining US Department of Energy $441,037.00 -------­
environmentally acceptable endpoints for 3/97-2100 
bioremediation of polychlorinated biphenyls 
(Co-PI) 
Photo-induced toxicity in Tetrahymena 	 University of Minnesota $ 19,063.00 $ 19,063.00 
1/94-12196 
A Eric Schultle 	 Vascular cell injury by toxicants of tall fescue grass USDA Formula Funds $ 5.000.00 -------­
(Co-PI) 
---------
I I I 	 I f I I f I I I I I I I I I I• 
J. Erby Wilkinson Role of agouti gene in tumorogenesis Lockheed Martin 	 $ 76,710.00 $ 41,562.97 
10101195-9/30/97 
Collaborative studies on the cellular and molecular Lockheed Martin $ 24,000.00 $ 21,208.71 
basis of disease in the scurfy mouse 7/29/96-7/28/97 
Genome analysis program Lockheed Martin 	 $ 75,195.00 
2196-9/30/97 $ 38,971.91 
Histopathologic and clinical pathology analyses of Lockheed Martin $ 102,250.00 
mice from a colony containing chromosomal 7/1195-3121198 
translocations $ 49,181.39 
Role of the agouti gene product on tumorogenesis Lockheed Martin 	 $ 67,000.00 
7/01/95-12131/96 
$ 25,720.20 
Directed expression of the agouti gene product in Glaxo $672,890.00 
transfenic mice: A potential model for obesity 10/93-9/96 
$ 77,389.90 
Manunalian genetics and development Lockheed Martin $ 70,850.00 
10/95-9/96 
$ 21,924.52 
Scurfy Mouse Lockheed Martin $ 41,391.00 
10/95-9/96 
, 
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 CENTER OF EXCELLENCE 
FACULTY FUNDED 1997-98 
-
David A. Bemis, Ph.D. 
Associate Professor 
Department of Comparative Medicine 
-
- Philip N. Bochsler, D.V.M., Ph.D. 
Assistant Professor 
Department of Pathology 
David A. Brian, D.V.M., Ph.D. 
Professor 
... Department of Microbiology 
Thomas J. Doherty, M.Sc. 
.. Assistant Professor 
Department of Large Animal Clinical Sciences 
-
Kevin A. Hahn, D.V.M., Ph.D. 
Associate Professor 
Department of Comparative Medicine 
.. 	 Alan G. Mathew, Ph.D. 
Assistant Professor 
Department of Animal Science 
.. Charmi Mendis-Handagama, D.V.M., Ph.D. 
Assistant Professor 
Department of Animal Science
- Joyce L Merryman, D.V.M., Ph.D. 
Assistant Professor 
.. Department of Pathology 
... 
-
.. 
.. 

.. 

.. 
Linda Munson, D.V.M., Ph.D. 
Assistant Professor 
Department of Pathology 
Jack W. Oliver, D.V.M., Ph.D. 
Professor 
Department of Comparative Medicine 
Stephen P. Oliver, D.V.M., Ph.D. 
Associate Professor 
Department of Animal Science 
Barton W. Rohrbach, V.M.D, M.P.H. 
Associate Professor 
Department of Large Animal Clinical Sciences 
Barry T. Rouse, B.V.Sc., Ph.D. 
Professor 
Department of Microbiology 
Hildegard M. Schuller, D.V.M., Ph.D • 
Professor 
Department of Pathology 
Terry W. Schultz, Ph.D. 
Professor 
Department of Animal Science 
J. Erby Wilkinson, D.V.M., Ph.D. 
Associate Professor 
Department of Pathology 
-

-
 Center of Excellence Plans for 1997-98 
-
No major changes in the direction of research within the Center are anticipated for the 
- next year. Most researchers have embarked on long-term research goals and some less­
established members are focusing on development of a fundable research niche. Generally, the 
- Center's research falls within two categories, livestock diseases or animalIIaboratory models of 
buman diseases. Researchers have concentrated on a limited number of focus areas within these 
two broad categories (Livestock diseases: infectious diseases/population medicine, toxicoses and 
reproduction; AnimalllaboratolY models: host defense, molecular genetics and carcinogenesis). 
- The general research goals for each of the research focus groups are as follows: 
-
Infectious DiseaseslPopulation Medicine 
Dr. David Brian will focus on the molecular biology ofbovine coronavirus replication; to 
-
study mechanism( s) of persistent infections and to identify targets for antiviral therapy and for 
.. 
engineering effective vaccines. 
Dr. Stephen Oliver will research virulence factors that have an important role in the
.. 
development of bovine mastitis caused by bacteria and whether such factors must be considered in 
the development ofvaccines.
- Dr. Sharon Patton continues to investigate the epidemiology and risk factors of 
Toxoplasma gondii, a parasite responsible for serious disease in fetuses, neonates and immuno­
-
-
deficient individuals. It affects humans and various animals. 
Dr. Melissa Kennedy will characterize molecular inter-relationships and diagnosis of 
coronavirus infections in animals. She will concentrate on identifying persistently infected animal 
and carriers of the virus. 
-
Dr. Alan Mathew will continue his study on factors influencing the incidence and severity 
_ of mastitis in sows. He also will investigate the influence of diet on the resistance of post-weaning 
pigs to intestinal infections. 
Dr. David Bemis has identified a major immunizing protein and virulence factor of 
-
Bordetella bronchiseptica, an important disease-producing agent of swine, horses, laboratory 
-
-
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-
animals and other animals. He will focus on characterizing the immune response to this protein 
produced by recombinant DNA technology. 
.. Toxicoses 
Dr. Terry Schultz will expand on his research on predicting the toxicity of highly reactive 
.. industrial materials using biological activity testing and mathematical modeling procedures . 
Dr. Jack Oliver and co-workers will study the effect of alkaloid fungal toxins in tall 
.. fescue grass on blood vessels of cattle. Chronic exposure to the toxins results in damage to the 
lining of blood vessels and mechanisms to prevent damage are being investigated. They also will 
.. 
continue to elucidate mechanisms by which these alkaloids, so prevalent on tall fescue grass, 
affect only herbivores. They also will work on improving their patented vaccine to prevent the 
.. 
.. 

harmful effects of the toxins. 

Dr. Donita Frazier will complete work on the cytochrome P450 enzymes that could 

affect the amount ofdrug or chemical residues in food animals. 
- Reproduction 
Dr. James Godkin will research treatments to manipulate production of vitamin A 
-
derivatives during ovulation and pregnancy to optimize reproductive efficiency in food animals. 
.. Dr. Charmi Mendis-Handagama will continue her research focus on hormonal 
mechanisms of fertility in animals and humans . 
.. 
Host Defense 
-
-
- Dr. Barry Rouse will concentrate on factors that modulate the severity of harmful 
inflammatory responses to herpesvirus infections. His approach is to use products of immune 
cells, produced by recombinant DNA technology, to ameliorate the degree of the host response to 
the virus. Dr. Rouse has pioneered the use of naked DNA vaccines and will continue to evaluate 
the utility of this approach for preventing infectious diseases. 
.. Dr. Philip Bochsler will continue to investigate the mechanisms by which white blood 
cells provide protection against infectious agents that cause bovine pneumonia. Dr. Bochsler also 
.. is studying the role of nitric oxide as a mediator of host defense in the lungs of cattle. Knowledge 
20
-
-

-
 of the function of leukocytes and other immune mechanisms operative in the bovine lung will 
-
assist in formulating improved strategies for prevention and therapy of bovine respiratory- tract 
disease. 
-
Dr. Diane Hendrix will determine, in a laboratory model, the effect of various commonly 
used antibiotics on the healing ofwounds to the cornea . 
.. 
-
Molecular Genetics 
Dr. Eric Schultze will work on a mutant mouse model of a specific type of anemia and 
.. 
Iron overload disease in people. He will characterize the molecular control of blood cell 
formation, iron metabolism and bone growth. 
-
Dr. Erby Wilkinson is characterizing and studying several diseases in mutant mice that 
resemble serious genetic diseases of humans. They include various auto-immune diseases, other 
.. 
immune-mediated diseases and Wiskott-Aldrich disease (see Goals 3 and 4). They have already 
had some success in curing and preventing some of these diseases. He will collaborate with Dr. 
-
Dorcas SchaetTer in further characterizing another disease in mutant mice that develop various 
organ abnormalities due to defect(s) in various stem (precursor) cells. 
.. Dr. Darryl Millis uses a canine model to investigate factors that influence healing of bone 
fractures. His work has focused on the use ofgrowth hormone. 
-
-
Carcinogenesis 
Dr. Hildegard Schuller will continue her work on the molecular mechanisms by which 
.. 
nicotine produces lung cancer and confirms whether drugs widely used for asthma and chronic 
bronchitis promote certain kinds of lung tumors in animal models. Dr. Schuller will continue the 
.. 
experiment in a hamster model to test the potential chemo-preventive effect of theophylline on 
this lung cancer type. Along with Dr. Joyce Merryman, she will continue to address the 
-
question why chronic lung disease is a risk factor for lung cancer. 
Dr. Kevin Hahn will conduct clinical trials on animals with naturally occuning cancer as 
-
models to identify new methods for the diagnosis and treatment of cancer. Dr. Hahn also is 
-
-
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.. 
-
attempting to identify, develop and evaluate new drugs that may augment standard anticancer 
drugs by minimizing resistance of tumor cells to the latter drugs. 
Dr. Joyce Merryman is studying the mechanism by which cells are affected by 
environmental hazards, especially ultraviolet radiation present in sunlight. Ultraviolet radiation 
causes damage to the cellular DNA. resulting in the necessary changes for skin cancer to develop. 
Dr. Merryman will investigate the role of tumor suppressor genes, growth-regulatory factors and 
intracellular communication pathways that are involved in the development of skin cancer. 
.. 
-
-
.. 
.. 
-
-
-
-
-
-
-
-
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Schedule 7 Budget Form 1998-99 
CENTERS OF EXCELLENCE/CENTERS OF EMPHASIS 
ACTUAL, PROPOSED, AND REQUESTED BUDGET 
Institution ...:.";.;::.e~ge;;....;;..of;,...V~e...:.te;.;.ri_n_a...:ry_M_e.....d;,...ic.....i ..:.ne;;...-___________Center Livestock Diseases and Human Health 
res 
Total Salaries 
Books & Journals 
Other S lies 
Maintenance 
Sch 
Consultants 
Renovation 
Other 
107,979 35,888 71,775 107,663 
29782 
40,445 15,413 30,826 46,239 
301180 561 179123 
518 1 035 1,553 1,278 3,835 
279 559 838 0 
99 197 296 0 
42,955 910 128,865 220,963 
82467 164,934 152,528 
4,267 
7,278 14,555 21 ,833 7,667 15,333 23,000 
0 0 
0 0 
0 0 
0 0 
0 0 
0 0 
503,100 503,100 
6,455 6,455 o 
29,750 500 
37682 75,364 
10,423 20,848 31,271 
1 184 32,367 551 
94,039 188,079 118 
1,342 
0 
0 
77,337 154,674 011 
385 106,769 160,154 
7,824 15 
8,050 16100 24,150 
0 
0 
0 
0 
0 
0 
528,255 528,255 
o 
257,150 257150 251,550 264,127 127 
, 

/ 
". 
J 
. I' 
/ 
\' 
Publication #R180101-13-001-98 
The University of Tennessee offers its programs to all eligible persons regardless of race, sex, 
disability or national origin and is an Equal Oppo~unity Employer. 
